SHIELD THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.35 GBX | +10.20% |
|
-8.47% | -79.85% |
| 02-22 | Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024 | |
| 02-21 | FTSE 100 takes hit ahead of FOMC minutes | AN |
Quotes 5-day view
Delayed Quote London S.E.| 23/04/2024 | 24/04/2024 | 25/04/2024 | 26/04/2024 | |
|---|---|---|---|---|
| Last | 1.425 p | 1.325 p | 1.225 p | 1.35 p |
| Volume | 700 061 | 2 958 047 | 8 963 337 | 8 345 835 |
| Change | 0.00% | -7.02% | -7.55% | +10.20% |
| Opening | 1.43 | 1.43 | 1.33 | 1.23 |
| High | 1.43 | 1.45 | 1.31 | 1.40 |
| Low | 1.40 | 1.30 | 1.06 | 1.20 |
Performance
| 1 day | +10.20% | ||
| 1 week | -8.47% | ||
| Current month | -33.33% | ||
| 1 month | -33.33% | ||
| 3 months | -78.40% | ||
| 6 months | -77.12% | ||
| Current year | -79.85% | ||
| 1 year | -81.63% | ||
| 3 years | -97.03% | ||
| 5 years | -98.51% |
Volumes
marketsDaily volume
8 160 121
Estimated daily volume
8 160 121
Avg. Volume 20 sessions
3 724 098
Daily volume ratio
2.19
Avg. Volume 20 sessions GBX
5 027 532.30
Avg. Volume 20 sessions USD
5 027 532.30
Record volume 1
165 039 100
Record volume 2
50 925 440
Record volume 3
38 827 200
Capital turnover ratio
0.00
Float rotation
0.01
Basic data
Capitalization (GBX)
10 499 749
Capitalization (USD)
13 150 516
Net sales (GBP)
4 467 000
Net sales (USD)
5 594 739
Number of employees
27
Sales / Employee (GBP)
165 444
Sales / Employee (USD)
207 213
Free-Float
43.82 %
Free-Float capitalization (GBX)
4 601 163
Free-Float capitalization (USD)
5 762 773
Average Daily Capital Traded
47.88%
Highs and lows
1 week
1.06
1.45
1 month
1.062.10
Current year
1.067.80
1 year
1.0612.85
3 years
1.0662.60
5 years
1.06202.00
10 years
1.06202.00
Indicators
Moving average 5 days
1.35
Moving average 20 days
1.61
Moving average 50 days
2.40
Moving average 100 days
4.39
Price spread / (MMA5)
0.00%
Price spread / (MMA20)
+19.12%
Price spread / (MMA50)
+77.99%
Price spread / (MMA100)
+224.93%
STIM
RSI 9 days
6.93
RSI 14 days
12.17
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +10.20% | -8.47% | -79.85% | -81.63% | 13.15M | ||
| -0.06% | +0.81% | -2.31% | +16.66% | 103B | ||
| -0.84% | -1.52% | +0.56% | +10.15% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +0.17% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -23.66% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.69% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -36.44% | 16.73B | ||
| +3.38% | +18.58% | -14.85% | -39.76% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +34.59% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +4.89% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -34.07% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +248.71% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +94.25% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +46.25% | 7.71B | ||
| +6.97% | +12.81% | -51.22% | -68.95% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +29.51% | 6.99B | ||
| Average | +2.32% | +3.25% | +6.53% | +10.69% | ||
| Weighted average by Cap. | +0.62% | +1.87% | +2.15% | +9.58% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
9ba3485f5ecc07ec0938c09.dnwQ6LaL_QDMDgU-vcLaqCzNUUUw-rcEUlx6Sf2nvzM.QDcpr_7EpDCNXTdZ15i2yRqOGyh0vvtRBwMWDbKf22tOEECH98KMebtfSA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 16:26:42 | 1.4 | 15,000 | 8,160,121 |
| 16:25:57 | 1.394 | 588,235 | 8,145,121 |
| 16:19:49 | 1.349 | 88,587 | 7,556,886 |
| 15:59:41 | 1.35 | 25,000 | 7,468,299 |
| 15:57:45 | 1.35 | 100,000 | 7,443,299 |
| 15:57:20 | 1.347 | 593,466 | 7,343,299 |
| 15:56:35 | 1.34 | 521,940 | 6,749,833 |
| 15:46:31 | 1.265 | 590 | 6,227,893 |
| 15:40:58 | 1.3 | 100,000 | 6,227,303 |
Monthly variations
Annual change
| 2024 | -79.85% | ||
| 2023 | -4.96% | ||
| 2022 | -84.16% | ||
| 2021 | -29.92% | ||
| 2020 | -64.53% | ||
| 2019 | +486.89% | ||
| 2018 | -72.89% | ||
| 2017 | -34.97% | ||
| 2016 | +10.19% |
- Stock Market
- Equities
- STX Stock
- Quotes Shield Therapeutics plc
